ZNTL
#3275
Zentalis Pharmaceuticals, Inc. - common stock
4.4 2 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.78%
Monthly Change
+20.11%
6 month change
+52.94%
Year Change
+194.67%
Previous Close
4.5 0
Open
4.5 2
Low
4.4 1
High
4.5 2
Volume
186
Financials
- Market Capitalization 314.64 M
- Employee 106
- Founded 2014
- CEO N/A
- Website www.zentalis.com
- Headquarter California, United States
- FIGI BBG00R2K8TF5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.34
Price to sales ratio
411.04
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3220 |  CTNM Contineum Therapeutics, Inc. - Common stock | 14.45 USD | -1.90% | +2.48% | +21.12% | -5.37% | 333.78 M USD | ||
| 3254 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.34 USD | -0.19% | -2.55% | -10.55% | -3.44% | 321.12 M USD | ||
| 3295 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.72 USD | +2.64% | +6.25% | -29.53% | +43.16% | 308.02 M USD | ||
| 3305 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 3.81 USD | -3.05% | -9.72% | -12.61% | +314.13% | 303.45 M USD |
Frequently asked questions about Zentalis Pharmaceuticals, Inc. - common stock
What is the Zentalis Pharmaceuticals, Inc. - common stock stock price today?
The current price of Zentalis Pharmaceuticals, Inc. - common stock (ZNTL) is 4.42. Over the past 24 hours, the stock has changed by -1.78%. Follow the ZNTL chart for real-time price dynamics.
What is the stock ticker of Zentalis Pharmaceuticals, Inc. - common stock?
Zentalis Pharmaceuticals, Inc. - common stock trades under the ticker ZNTL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zentalis Pharmaceuticals, Inc. - common stock stock going up?
ZNTL has changed by -2.21% over the last week, +20.11% over the last month, and +194.67% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Zentalis Pharmaceuticals, Inc. - common stock net income for the last quarter?
Zentalis Pharmaceuticals, Inc. - common stock reported net income of -35.35 M for the last quarter. The previous quarter showed -35.22 M, which means net income changed by -0.39%.
How many employees does Zentalis Pharmaceuticals, Inc. - common stock have?
As of the latest available data, Zentalis Pharmaceuticals, Inc. - common stock has 106 employees. Workforce size can provide additional context about the company's scale and operations.
What is Zentalis Pharmaceuticals, Inc. - common stock EBITDA?
Zentalis Pharmaceuticals, Inc. - common stock EBITDA is -37.3 M, and its EBITDA margin is -9 326%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Zentalis Pharmaceuticals, Inc. - common stock stock?
You can buy Zentalis Pharmaceuticals, Inc. - common stock (ZNTL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zentalis Pharmaceuticals, Inc. - common stock stock?
Investing in Zentalis Pharmaceuticals, Inc. - common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZNTL chart and related analysis on metatrader.com as part of your research.